SHAREHOLDER ALERT: Pomerantz LLP Investigates Claims That the Merger May Not Be in the Best Interest of Investors of Supertex, Inc. - SUPX
NEW YORK, Feb. 10, 2014 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Supertex, Inc. ("Supertex" or the "Company") (NasdaqGS: SUPX) (ISIN: US8685321023) (CUSIP: 868532102) concerning the proposed acquisition of Supertex by Microchip Technology Inc.
The investigation concerns whether the Supertex directors are breaching their fiduciary duties by failing to adequately shop the Company and maximize shareholder value. Under the terms of the agreement, shares of Supertex will be converted into the right to receive $33.00 in cash for each share of Supertex common stock. However, the Price to Book Value multiple is below the average of comparable transactions, and expected synergies may not be fully reflected in the offered price.
Supertex shareholders seeking more information about this acquisition are advised to contact Robert Willoughby at [email protected] or 212-661-1100 or 888-476-6529, ext. 237.
Pomerantz LLP, with offices in New York, Chicago, Florida, and San Diego, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz LLP pioneered the field of securities class actions. Today, more than 75 years later, the Pomerantz LLP continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of defrauded investors. See www.pomerantzlaw.com.
CONTACT:
Robert Willoughby
Pomerantz LLP
212-661-1100 ext. 237
[email protected]
SOURCE Pomerantz LLP
Share this article